0001123292-16-003026.txt : 20161205
0001123292-16-003026.hdr.sgml : 20161205
20161205164700
ACCESSION NUMBER: 0001123292-16-003026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161201
FILED AS OF DATE: 20161205
DATE AS OF CHANGE: 20161205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myers Diane
CENTRAL INDEX KEY: 0001602335
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 162034283
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-12-01
0001588972
Recro Pharma, Inc.
REPH
0001602335
Myers Diane
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
1
0
0
0
Common Stock
2016-12-01
4
M
0
2500
A
4060
D
Common Stock
2016-12-01
4
F
0
777
6.48
D
3283
D
On December 1, 2016, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 2,500 performance-based restricted stock units, which were converted into 2,500 shares of common stock on a one-for-one basis.
/s/ Donna Nichols, attorney-in-fact
2016-12-05